Viewing Study NCT06317805


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2026-02-25 @ 12:22 AM
Study NCT ID: NCT06317805
Status: RECRUITING
Last Update Posted: 2024-03-19
First Post: 2024-02-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Sponsor: AOP Orphan Pharmaceuticals AG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module